© 2022 MJH Life Sciences and Cancer Network. All rights reserved.
© 2022 MJH Life Sciences™ and Cancer Network. All rights reserved.
Virginia Kaklamani, MD, DSc, provides a discussion on the frontline and maintenance therapies available for the management of early-stage HER2+ breast cancer.
February 1st 2022
Virginia Kaklamani, MD, DSc, provides an overview of the goals of care for HER2+ breast cancer.
A review of the currently available frontline treatment options for HER2+ breast cancer.
February 8th 2022
Dr. Virginia Kaklamani discusses the role of maintenance therapies for HER2+ breast cancer.
February 15th 2022
Advice for community physicians treating HER2+ breast cancer.